Safety and efficacy of once-weekly dulaglutide versus sitagliptin after 2 years in metformin-treated patients with type 2 diabetes (AWARD-5): a randomized, phase III study - Weinstock, R S; Guerci, B; Umpierrez, G (Diabetes Obes Metab, 2015)
et al